Charcoal and Nexium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Charcoal (activated charcoal) and Nexium (esomeprazole magnesium). Common drug interactions include fatigue among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Charcoal and Nexium. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Charcoal?

Charcoal has active ingredients of activated charcoal. eHealthMe is studying from 1,179 Charcoal users. Check the latest studies of Charcoal.

What is Nexium?

Nexium has active ingredients of esomeprazole magnesium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 245,677 Nexium users. Check the latest studies of Nexium.



On Jul, 18, 2026

15 people who take Charcoal and Nexium together, and have interactions are studied.

Charcoal and Nexium drug interactions.

What are the common drug interactions of Charcoal and Nexium, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Hypotonia (low muscle tone)
  3. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
  4. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)
  5. Migraine (headache)
  6. Mycotoxicosis (diseases caused by the effects of toxins produced by moulds)
  7. Sleep disorder
  8. Tongue ulceration (ulcers on tongue)
  9. Tracheal obstruction (blockage of trachea)
  10. Weight decreased

male:

  1. Dizziness
  2. Dyspnoea (difficult or laboured respiration)
  3. Feeling hot

What are the common drug interactions of Charcoal and Nexium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Acidosis (build-up of carbon dioxide in the blood)
  2. Flatulence (flatus expelled through the anus)
  3. Hepatic enzyme increased
  4. Hypokalaemia (low potassium)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anaemia (lack of blood)
  2. Asthenia (weakness)
  3. Blood pressure increased
  4. Dysphagia (a condition in which swallowing is difficult or painful)
  5. Fatigue (feeling of tiredness)
  6. Hypotonia (low muscle tone)
  7. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
  8. Initial insomnia (feeling of inadequate or poor-quality sleep)
  9. Insomnia (sleeplessness)
  10. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)

50-59:

  1. Anaemia (lack of blood)
  2. Blood pressure increased
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Fatigue (feeling of tiredness)
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Hypotonia (low muscle tone)
  7. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
  8. Injection site pain
  9. Irritable bowel syndrome
  10. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Dyspnoea (difficult or laboured respiration)
  5. Feeling hot
  6. Flatulence (flatus expelled through the anus)
  7. Nausea (feeling of having an urge to vomit)
  8. Pain
  9. Partial seizures (seizures which affect only a part of the brain at onset)
  10. Urinary tract infection

What are the existing conditions these people have? *

  1. Muscle Disorder (muscle disease): 2 people, 13.33%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 13.33%
  3. Balance Disorder: 2 people, 13.33%
  4. Chronic Fatigue Syndrome (disorder that causes extreme fatigue): 2 people, 13.33%
  5. Dizziness: 2 people, 13.33%
  6. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 6.67%
  7. Detrusor Sphincter Dyssynergia (lack of external sphincter relaxation during voluntary voiding): 1 person, 6.67%
  8. Acidosis (build-up of carbon dioxide in the blood): 1 person, 6.67%
  9. Anaemia (lack of blood): 1 person, 6.67%
  10. Arrhythmias (irregular heartbeat): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Charcoal and Nexium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Charcoal and Nexium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Charcoal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nexium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Charcoal and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nexium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on activated charcoal and esomeprazole magnesium (the active ingredients of Charcoal and Nexium, respectively), and Charcoal and Nexium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: